RegeniTherix™ combines therapeutic (scaffold) and diagnostic (hydrogel capture of biomarkers) technologies.

  • Scaffold and hydrogel components are designed to work together to facilitate the collection and sampling of biomarkers produced by the patient’s ingressing cells involved in the wound healing process;
  • Resulting in an accurate and minimally invasive method to sample wound biomarkers and gain information on the prospects that a particular wound will heal.



Completed pre-clinical testing
Gained proof of concept
Awarded 2 large grants from Innovate UK and i4i
Awarded Bionow project of the year 2015
Obtained First in Man clinical investigation approval
US patent for biomarker sampling was granted to Neotherix in 2020 (US 10,687,790)

Get in touch with us

We’re always happy to hear from potential investors and funding partners as well as researchers, universities and networks interested in our products and development work.